Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors (CNTO95/Avastin)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Centocor, Inc.
Genentech
Information provided by (Responsible Party):
Herbert Hurwitz, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT00888043
First received: April 23, 2009
Last updated: April 4, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)